DOI: 10.1038/77558. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

10.1038/77558

Crossref journal-article

Springer Science and Business Media LLC

Nature Medicine (297)

Bibliography

Stojdl, D. F., Lichty, B., Knowles, S., Marius, R., Atkins, H., Sonenberg, N., & Bell, J. C. (2000). Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nature Medicine, 6(7), 821â825.

Authors 7

David F. Stojdl (first)
Brian Lichty (additional)
Shane Knowles (additional)
Ricardo Marius (additional)
Harold Atkins (additional)
Nahum Sonenberg (additional)
John C. Bell (additional)

References 21 Referenced 674

Stark, G.R., Kerr, I.M., Williams, B.R., Silverman, R.H. & Schreiber, R.D. How cells respond to interferons . Annu. Rev. Biochem. 67, 227– 264 (1998). (10.1146/annurev.biochem.67.1.227) / Annu. Rev. Biochem. by GR Stark (1998)
Kloke, O. & Niederle, N. Development and mechanisms of interferon resistance. Cancer Treat. Rev. 17 Suppl A, 81–88 (1990). (10.1016/0305-7372(90)90019-C) / Cancer Treat. Rev. by O Kloke (1990)
Colamonici, O.R., Domanski, P., Platanias, L.C. & Diaz, M.O. Correlation between interferon (IFN) alpha resistance and deletion of the IFN α/β genes in acute leukemia cell lines suggests selection against the IFN system. Blood 80, 744– 749 (1992). (10.1182/blood.V80.3.744.744) / Blood by OR Colamonici (1992)
Xu, B., Grandér, D., Sangfelt, O. & Einhorn, S. Primary leukemia cells resistant to alpha-interferon in vitro are defective in the activation of the DNA-binding factor interferon-stimulated gene factor 3. Blood 84, 1942–1949 (1994). (10.1182/blood.V84.6.1942.1942) / Blood by B Xu (1994)
Wong, L.H. et al. Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma. J. Biol. Chem. 272, 28779–28785 (1997). (10.1074/jbc.272.45.28779) / J. Biol. Chem. by LH Wong (1997)
Abril, E. et al. Characterization of a gastric tumor cell line defective in MHC class I inducibility by both alpha- and gamma-interferon. Tissue Antigens 47, 391–398 ( 1996). (10.1111/j.1399-0039.1996.tb02574.x) / Tissue Antigens by E Abril (1996)
Sun, W.H. et al. Interferon-alpha resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression. Blood 91, 570–576 (1998). (10.1182/blood.V91.2.570) / Blood by WH Sun (1998)
Letchworth, G.J., Rodriguez, L.L. & Del cbarrera, J. Vesicular stomatitis. Vet. J. 157, 239–260 (1999). (10.1053/tvjl.1998.0303) / Vet. J. by GJ Letchworth (1999)
Belkowski, L.S. & Sen, G.C. Inhibition of vesicular stomatitis viral mRNA synthesis by interferons. J. Virol. 61, 653–660 (1987). (10.1128/JVI.61.3.653-660.1987) / J. Virol. by LS Belkowski (1987)
Burke, F. Cytokines (IFNs, TNF-α, IL-2 and IL-12) and animal models of cancer . Cytokines Cell. Mol. Ther. 5, 51– 61 (1999). / Cytokines Cell. Mol. Ther. by F Burke (1999)
Thomsen, A.R. et al. Cooperation of B cells and T cells is required for survival of mice infected with vesicular stomatitis virus. Int. Immunol. 9, 1757–1766 ( 1997). (10.1093/intimm/9.11.1757) / Int. Immunol. by AR Thomsen (1997)
Huneycutt, B.S., Bi, Z., Aoki, C.J. & Reiss, C.S. Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice. J. Virol. 67, 6698–6706 (1993). (10.1128/JVI.67.11.6698-6706.1993) / J. Virol. by BS Huneycutt (1993)
Coukos, G. et al. Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancer. Clin. Cancer Res. 5, 1523– 1537 (1999). / Clin. Cancer Res. by G Coukos (1999)
Smith, R.R., Huebner, R.J., Rowe, W.P., Schatten, W.E. & Thomas, L.B. Studies on the use of viruses in the treatment of carcinomas of the cervix. Cancer 9 , 1211–1218 (1956). (10.1002/1097-0142(195611/12)9:6<1211::AID-CNCR2820090624>3.0.CO;2-7) / Cancer by RR Smith (1956)
Lorence, R.M. > et al. Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy. Cancer Res. 54, 6017–6021 (1994). / Cancer Res. by RM Lorence (1994)
Lorence, R.M. et al. Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy. J. Natl. Cancer Inst. 86, 1228–1233 ( 1994). (10.1093/jnci/86.16.1228) / J. Natl. Cancer Inst by RM Lorence (1994)
Rothmann, T., Hengstermann, A., Whitaker, N.J., Scheffner, M. & zur Hausen, H. Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells. J. Virol. 72, 9470–9478 (1998). (10.1128/JVI.72.12.9470-9478.1998) / J. Virol. by T Rothmann (1998)
Shimada, A. et al. Aberrant expression of double-stranded RNA-dependent protein kinase in hepatocytes of chronic hepatitis and differentiated hepatocellular carcinoma. Cancer Res. 58, 4434– 4438 (1998). / Cancer Res. by A Shimada (1998)
Strong, J.E., Coffey, M.C., Tang, D., Sabinin, P. & Lee, P.W. The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J. 17, 3351–3362 (1998). (10.1093/emboj/17.12.3351) / EMBO J. by JE Strong (1998)
Cassady, K.A., Gross, M. & Roizman, B. The herpes simplex virus US11 protein effectively compensates for the gamma1(34.5) gene if present before activation of protein kinase R by precluding its phosphorylation and that of the alpha subunit of eukaryotic translation initiation factor 2. J. Virol. 72, 8620–8626 (1998). (10.1128/JVI.72.11.8620-8626.1998) / J. Virol. by KA Cassady (1998)
Cave, D.R., Hendrickson, F.M. & Huang, A.S. Defective interfering virus particles modulate virulence . J. Virol. 55, 366–373 (1985). (10.1128/JVI.55.2.366-373.1985) / J. Virol. by DR Cave (1985)

Dates

Type	When
Created	23 years, 1 month ago (July 26, 2002, 4:34 a.m.)
Deposited	2 years, 3 months ago (May 18, 2023, 7 p.m.)
Indexed	1 week, 5 days ago (Aug. 24, 2025, 7:08 p.m.)
Issued	25 years, 2 months ago (July 1, 2000)
Published	25 years, 2 months ago (July 1, 2000)
Published Print	25 years, 2 months ago (July 1, 2000)

Funders 0

None

BibTeX

@article{Stojdl_2000, title={Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus}, volume={6}, ISSN={1546-170X}, url={http://dx.doi.org/10.1038/77558}, DOI={10.1038/77558}, number={7}, journal={Nature Medicine}, publisher={Springer Science and Business Media LLC}, author={Stojdl, David F. and Lichty, Brian and Knowles, Shane and Marius, Ricardo and Atkins, Harold and Sonenberg, Nahum and Bell, John C.}, year={2000}, month=jul, pages={821–825} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        8,
        24
      ]
    ],
    "date-time": "2025-08-24T23:08:20Z",
    "timestamp": 1756076900797
  },
  "reference-count": 21,
  "publisher": "Springer Science and Business Media LLC",
  "issue": "7",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2000,
            7,
            1
          ]
        ],
        "date-time": "2000-07-01T00:00:00Z",
        "timestamp": 962409600000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "http://www.springer.com/tdm"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2000,
        7
      ]
    ]
  },
  "DOI": "10.1038/77558",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2002,
        7,
        26
      ]
    ],
    "date-time": "2002-07-26T08:34:58Z",
    "timestamp": 1027672498000
  },
  "page": "821-825",
  "source": "Crossref",
  "is-referenced-by-count": 674,
  "title": "Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus",
  "prefix": "10.1038",
  "volume": "6",
  "author": [
    {
      "given": "David F.",
      "family": "Stojdl",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Brian",
      "family": "Lichty",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Shane",
      "family": "Knowles",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Ricardo",
      "family": "Marius",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Harold",
      "family": "Atkins",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Nahum",
      "family": "Sonenberg",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "John C.",
      "family": "Bell",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "297",
  "reference": [
    {
      "key": "BFnm0700_821_CR1",
      "doi-asserted-by": "publisher",
      "first-page": "227",
      "DOI": "10.1146/annurev.biochem.67.1.227",
      "volume": "67",
      "author": "GR Stark",
      "year": "1998",
      "unstructured": "Stark, G.R., Kerr, I.M., Williams, B.R., Silverman, R.H. & Schreiber, R.D. How cells respond to interferons . Annu. Rev. Biochem. 67, 227\u2013 264 (1998).",
      "journal-title": "Annu. Rev. Biochem."
    },
    {
      "issue": "A",
      "key": "BFnm0700_821_CR2",
      "doi-asserted-by": "publisher",
      "first-page": "81",
      "DOI": "10.1016/0305-7372(90)90019-C",
      "volume": "17",
      "author": "O Kloke",
      "year": "1990",
      "unstructured": "Kloke, O. & Niederle, N. Development and mechanisms of interferon resistance. Cancer Treat. Rev. 17 Suppl A, 81\u201388 (1990).",
      "journal-title": "Cancer Treat. Rev."
    },
    {
      "key": "BFnm0700_821_CR3",
      "doi-asserted-by": "crossref",
      "first-page": "744",
      "DOI": "10.1182/blood.V80.3.744.744",
      "volume": "80",
      "author": "OR Colamonici",
      "year": "1992",
      "unstructured": "Colamonici, O.R., Domanski, P., Platanias, L.C. & Diaz, M.O. Correlation between interferon (IFN) alpha resistance and deletion of the IFN \u03b1/\u03b2 genes in acute leukemia cell lines suggests selection against the IFN system. Blood 80, 744\u2013 749 (1992).",
      "journal-title": "Blood"
    },
    {
      "key": "BFnm0700_821_CR4",
      "doi-asserted-by": "crossref",
      "first-page": "1942",
      "DOI": "10.1182/blood.V84.6.1942.1942",
      "volume": "84",
      "author": "B Xu",
      "year": "1994",
      "unstructured": "Xu, B., Grand\u00e9r, D., Sangfelt, O. & Einhorn, S. Primary leukemia cells resistant to alpha-interferon in vitro are defective in the activation of the DNA-binding factor interferon-stimulated gene factor 3. Blood 84, 1942\u20131949 (1994).",
      "journal-title": "Blood"
    },
    {
      "key": "BFnm0700_821_CR5",
      "doi-asserted-by": "publisher",
      "first-page": "28779",
      "DOI": "10.1074/jbc.272.45.28779",
      "volume": "272",
      "author": "LH Wong",
      "year": "1997",
      "unstructured": "Wong, L.H. et al. Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma. J. Biol. Chem. 272, 28779\u201328785 (1997).",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "BFnm0700_821_CR6",
      "doi-asserted-by": "publisher",
      "first-page": "391",
      "DOI": "10.1111/j.1399-0039.1996.tb02574.x",
      "volume": "47",
      "author": "E Abril",
      "year": "1996",
      "unstructured": "Abril, E. et al. Characterization of a gastric tumor cell line defective in MHC class I inducibility by both alpha- and gamma-interferon. Tissue Antigens 47, 391\u2013398 ( 1996).",
      "journal-title": "Tissue Antigens"
    },
    {
      "key": "BFnm0700_821_CR7",
      "doi-asserted-by": "crossref",
      "first-page": "570",
      "DOI": "10.1182/blood.V91.2.570",
      "volume": "91",
      "author": "WH Sun",
      "year": "1998",
      "unstructured": "Sun, W.H. et al. Interferon-alpha resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression. Blood 91, 570\u2013576 (1998).",
      "journal-title": "Blood"
    },
    {
      "key": "BFnm0700_821_CR8",
      "doi-asserted-by": "publisher",
      "first-page": "239",
      "DOI": "10.1053/tvjl.1998.0303",
      "volume": "157",
      "author": "GJ Letchworth",
      "year": "1999",
      "unstructured": "Letchworth, G.J., Rodriguez, L.L. & Del cbarrera, J. Vesicular stomatitis. Vet. J. 157, 239\u2013260 (1999).",
      "journal-title": "Vet. J."
    },
    {
      "key": "BFnm0700_821_CR9",
      "doi-asserted-by": "crossref",
      "first-page": "653",
      "DOI": "10.1128/JVI.61.3.653-660.1987",
      "volume": "61",
      "author": "LS Belkowski",
      "year": "1987",
      "unstructured": "Belkowski, L.S. & Sen, G.C. Inhibition of vesicular stomatitis viral mRNA synthesis by interferons. J. Virol. 61, 653\u2013660 (1987).",
      "journal-title": "J. Virol."
    },
    {
      "key": "BFnm0700_821_CR10",
      "first-page": "51",
      "volume": "5",
      "author": "F Burke",
      "year": "1999",
      "unstructured": "Burke, F. Cytokines (IFNs, TNF-\u03b1, IL-2 and IL-12) and animal models of cancer . Cytokines Cell. Mol. Ther. 5, 51\u2013 61 (1999).",
      "journal-title": "Cytokines Cell. Mol. Ther."
    },
    {
      "key": "BFnm0700_821_CR11",
      "doi-asserted-by": "publisher",
      "first-page": "1757",
      "DOI": "10.1093/intimm/9.11.1757",
      "volume": "9",
      "author": "AR Thomsen",
      "year": "1997",
      "unstructured": "Thomsen, A.R. et al. Cooperation of B cells and T cells is required for survival of mice infected with vesicular stomatitis virus. Int. Immunol. 9, 1757\u20131766 ( 1997).",
      "journal-title": "Int. Immunol."
    },
    {
      "key": "BFnm0700_821_CR12",
      "doi-asserted-by": "crossref",
      "first-page": "6698",
      "DOI": "10.1128/JVI.67.11.6698-6706.1993",
      "volume": "67",
      "author": "BS Huneycutt",
      "year": "1993",
      "unstructured": "Huneycutt, B.S., Bi, Z., Aoki, C.J. & Reiss, C.S. Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice. J. Virol. 67, 6698\u20136706 (1993).",
      "journal-title": "J. Virol."
    },
    {
      "key": "BFnm0700_821_CR13",
      "first-page": "1523",
      "volume": "5",
      "author": "G Coukos",
      "year": "1999",
      "unstructured": "Coukos, G. et al. Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancer. Clin. Cancer Res. 5, 1523\u2013 1537 (1999).",
      "journal-title": "Clin. Cancer Res."
    },
    {
      "key": "BFnm0700_821_CR14",
      "doi-asserted-by": "publisher",
      "first-page": "1211",
      "DOI": "10.1002/1097-0142(195611/12)9:6<1211::AID-CNCR2820090624>3.0.CO;2-7",
      "volume": "9",
      "author": "RR Smith",
      "year": "1956",
      "unstructured": "Smith, R.R., Huebner, R.J., Rowe, W.P., Schatten, W.E. & Thomas, L.B. Studies on the use of viruses in the treatment of carcinomas of the cervix. Cancer 9 , 1211\u20131218 (1956).",
      "journal-title": "Cancer"
    },
    {
      "key": "BFnm0700_821_CR15",
      "first-page": "6017",
      "volume": "54",
      "author": "RM Lorence",
      "year": "1994",
      "unstructured": "Lorence, R.M. &gt; et al. Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy. Cancer Res. 54, 6017\u20136021 (1994).",
      "journal-title": "Cancer Res."
    },
    {
      "key": "BFnm0700_821_CR16",
      "doi-asserted-by": "publisher",
      "first-page": "1228",
      "DOI": "10.1093/jnci/86.16.1228",
      "volume": "86",
      "author": "RM Lorence",
      "year": "1994",
      "unstructured": "Lorence, R.M. et al. Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy. J. Natl. Cancer Inst. 86, 1228\u20131233 ( 1994).",
      "journal-title": "J. Natl. Cancer Inst"
    },
    {
      "key": "BFnm0700_821_CR17",
      "doi-asserted-by": "crossref",
      "first-page": "9470",
      "DOI": "10.1128/JVI.72.12.9470-9478.1998",
      "volume": "72",
      "author": "T Rothmann",
      "year": "1998",
      "unstructured": "Rothmann, T., Hengstermann, A., Whitaker, N.J., Scheffner, M. & zur Hausen, H. Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells. J. Virol. 72, 9470\u20139478 (1998).",
      "journal-title": "J. Virol."
    },
    {
      "key": "BFnm0700_821_CR18",
      "first-page": "4434",
      "volume": "58",
      "author": "A Shimada",
      "year": "1998",
      "unstructured": "Shimada, A. et al. Aberrant expression of double-stranded RNA-dependent protein kinase in hepatocytes of chronic hepatitis and differentiated hepatocellular carcinoma. Cancer Res. 58, 4434\u2013 4438 (1998).",
      "journal-title": "Cancer Res."
    },
    {
      "key": "BFnm0700_821_CR19",
      "doi-asserted-by": "publisher",
      "first-page": "3351",
      "DOI": "10.1093/emboj/17.12.3351",
      "volume": "17",
      "author": "JE Strong",
      "year": "1998",
      "unstructured": "Strong, J.E., Coffey, M.C., Tang, D., Sabinin, P. & Lee, P.W. The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J. 17, 3351\u20133362 (1998).",
      "journal-title": "EMBO J."
    },
    {
      "key": "BFnm0700_821_CR20",
      "doi-asserted-by": "crossref",
      "first-page": "8620",
      "DOI": "10.1128/JVI.72.11.8620-8626.1998",
      "volume": "72",
      "author": "KA Cassady",
      "year": "1998",
      "unstructured": "Cassady, K.A., Gross, M. & Roizman, B. The herpes simplex virus US11 protein effectively compensates for the gamma1(34.5) gene if present before activation of protein kinase R by precluding its phosphorylation and that of the alpha subunit of eukaryotic translation initiation factor 2. J. Virol. 72, 8620\u20138626 (1998).",
      "journal-title": "J. Virol."
    },
    {
      "key": "BFnm0700_821_CR21",
      "doi-asserted-by": "crossref",
      "first-page": "366",
      "DOI": "10.1128/JVI.55.2.366-373.1985",
      "volume": "55",
      "author": "DR Cave",
      "year": "1985",
      "unstructured": "Cave, D.R., Hendrickson, F.M. & Huang, A.S. Defective interfering virus particles modulate virulence . J. Virol. 55, 366\u2013373 (1985).",
      "journal-title": "J. Virol."
    }
  ],
  "container-title": "Nature Medicine",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "http://www.nature.com/articles/nm0700_821.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/nm0700_821",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/nm0700_821.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T23:00:16Z",
    "timestamp": 1684450816000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/nm0700_821"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2000,
        7
      ]
    ]
  },
  "references-count": 21,
  "journal-issue": {
    "issue": "7",
    "published-print": {
      "date-parts": [
        [
          2000,
          7
        ]
      ]
    }
  },
  "alternative-id": [
    "BFnm0700_821"
  ],
  "URL": "http://dx.doi.org/10.1038/77558",
  "relation": {},
  "ISSN": [
    "1078-8956",
    "1546-170X"
  ],
  "subject": [],
  "container-title-short": "Nat Med",
  "published": {
    "date-parts": [
      [
        2000,
        7
      ]
    ]
  }
}